Given that BDTX has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank ...

Black Diamond Therapeutics, Inc. ( (BDTX)) has released its Q3 earnings. Here is a breakdown of the information Black Diamond Therapeutics, Inc. presented to its investors. Black Diamond ...

With a 36% objective response rate and encouraging durability, BDTX-1535 shows potential to address osimertinib resistance. The Dow Jones closed lower by around 250 points on Thursday. When ...

Black Diamond Therapeutic (NASDAQ:BDTX) just reported results for the second quarter of 2024. Black Diamond Therapeutic reported earnings per share of -36 cents. This was above the analyst ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...

Analyst Robert Burns of H.C. Wainwright reiterated a Buy rating on Black Diamond Therapeutics (BDTX – Research Report), retaining the price target of $11.00. Robert Burns has given his Buy ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

San Gabriel Project Completion: Reached 65% overall completion. Compania de Minas Buenaventura SAA (NYSE:BVN) reported a significant increase in EBITDA from direct operations, reaching $132 ...